Genesis Healthcare, Inc. (GEN): Price and Financial Metrics
GEN Stock Summary
- The price/operating cash flow metric for Genesis Healthcare Inc is higher than merely 1.85% of stocks in our set with a positive cash flow.
- With a price/sales ratio of 0.02, Genesis Healthcare Inc has a higher such ratio than only 0.19% of stocks in our set.
- Genesis Healthcare Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 157.64%, greater than the shareholder yield of 98.39% of stocks in our set.
- Stocks that are quantitatively similar to GEN, based on their financial statements, market capitalization, and price volatility, are CYH, TUP, STG, HX, and SVVC.
- Visit GEN's SEC page to see the company's official filings. To visit the company's web site, go to www.genesishcc.com.
GEN Stock Price Chart Interactive Chart >
GEN Price/Volume Stats
| Current price | $0.42 | 52-week high | $1.37 |
| Prev. close | $0.48 | 52-week low | $0.40 |
| Day low | $0.42 | Volume | 15,800,700 |
| Day high | $0.50 | Avg. volume | 7,520,979 |
| 50-day MA | $0.73 | Dividend yield | N/A |
| 200-day MA | $0.65 | Market Cap | 70.12M |
Genesis Healthcare, Inc. (GEN) Company Bio
Genesis Healthcare provides post-acute care services through a network of skilled nursing centers and assisted/senior living communities in the United States. It operates through three segments: Long-Term Care Services, Therapy Services, and Hospice and Home Health Services. The company was founded in 2003 and is based in Kennett Square, Pennsylvania.
Latest GEN News From Around the Web
Below are the latest news stories about Genesis Healthcare Inc that investors may wish to consider to help them evaluate GEN as an investment opportunity.
House subcommittee to explore impact on U.S. healthcare industry of private-equity ownershipOne topic to be addressed at Thursday hearing: prospective links between private-equity owners and elevated mortality rates and inspection outcomes. |
Highly Regarded Turnaround Specialist, Harry Wilson, Appointed CEO of Genesis HealthCareCompany to build on solid foundation and further strengthen patient care and resident experienceKENNETT SQUARE, Pa., March 23, 2021 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE: GEN), a national post-acute care provider, announced today that Harry Wilson has been appointed as the Company’s new Chief Executive Officer (CEO), replacing CEO, Robert (“Bob”) H. Fish. Mr. Wilson will also join the Company’s Board of Directors, replacing James McKeon. The Company also announced that David Harrington has been appointed Executive Chairman, and Mr. Fish will remain a member of the Board. Mr. Wilson’s focus will be on immediately developing and executing a turnaround plan for the Company, while building a foundation for future innovation and growth as a national lea... |
Genesis HealthCare Shares Are Trading Lower After Debt Restructuring Deal, Voluntary Delisting From NYSEWelltower Inc (NYSE: WELL) is cutting most ties with beleaguered Genesis HealthCare Inc (NYSE: GEN) and plans to terminate leases with Genesis for 51 of its properties and provide an $86 million lease termination fee upon their successful transition. Additionally, Genesis will conditionally receive approximately $170 million in additional debt reductions from Welltower. Hence, Genesis expects to reduce its debt outstanding to Welltower by approximately $256 million and extend the maturity to January 1, 2024. Welltower will also receive equity in Genesis, increasing its stake in Genesis from approximately 6% to about 15%. It has also secured a $50 million debt investment from ReGen Healthcare that would convert into equity representing a 25% stake in the company. ReGen Healthcare also ha... |
Welltower (WELL) Limits Genesis Ties, Enhances ProMedica JVWhile the future deployment of $745 million of Genesis transaction proceeds offers significant value accretion scope for Welltower (WELL), the sale of properties will result in earnings dilution. |
Genesis HealthCare Announces Strategic Restructuring Steps to Strengthen Balance Sheet and Chart Path for RecoveryTransformative steps reduce debt by approximately $256 million and include an immediate $50 million capital investmentOpportunity for an additional $25 million capital investment by April 15, 2021Initial capital investment results in two appointments to the Board of Directors and voluntary delisting from the New York Stock Exchange and deregistration under the Exchange Act KENNETT SQUARE, Pa., March 03, 2021 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (“Genesis” or the “Company”) (NYSE:GEN) announced today a three-part strategic restructuring plan to strengthen the Company’s liquidity position and capital structure as it charts a path to recovery. First, Genesis has agreed to terminate its master lease covering 51 facilities leased from affiliates of Welltower Inc. (“Welltower”) and tr... |
GEN Price Returns
| 1-mo | -28.01% |
| 3-mo | -42.11% |
| 6-mo | -18.40% |
| 1-year | -49.71% |
| 3-year | -75.86% |
| 5-year | -82.86% |
| YTD | -13.35% |
| 2020 | -70.45% |
| 2019 | 38.98% |
| 2018 | 54.65% |
| 2017 | -82.05% |
| 2016 | 22.48% |
Continue Researching GEN
Here are a few links from around the web to help you further your research on Genesis Healthcare Inc's stock as an investment opportunity:Genesis Healthcare Inc (GEN) Stock Price | Nasdaq
Genesis Healthcare Inc (GEN) Stock Quote, History and News - Yahoo Finance
Genesis Healthcare Inc (GEN) Stock Price and Basic Information | MarketWatch
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Loading social stream, please wait...